• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度至中度 COPD 中的合并症:与正常和限制性肺功能的比较。

Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function.

机构信息

Division of Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

出版信息

COPD. 2011 Dec;8(6):421-8. doi: 10.3109/15412555.2011.629858.

DOI:10.3109/15412555.2011.629858
PMID:22149402
Abstract

BACKGROUND

A relationship between local and systemic inflammation and different co-morbidities, such as cardiovascular, has been discussed in relation to disease process and prognosis in COPD.

AIM

To evaluate if conditions as cardiovascular diseases, diabetes, chronic rhinitis and gastroesophageal reflux are overrepresented in COPD.

METHODS

All subjects with COPD according to GOLD, FEV(1)/FVC<0.70, were identified (n = 993) from the clinical follow-up in 2002-04 of the OLIN (Obstructive Lung Disease in Northern Sweden) studies' cohorts together with 993 gender- and age-matched reference subjects without COPD (non-COPD, further divided into normal and restrictive lung function). Interview data on co-morbidity and symptoms were used.

RESULTS

Cardiovascular co-morbidity, taken together heart disease, hypertension, stroke and intermittent claudication, was the most common and higher in COPD compared to in normal lung function (Nlf) 50.1% vs 41.0% (p<0.001). The prevalence of chronic rhinitis and gastroesophageal reflux (GERD) was higher in COPD compared to in Nlf (43.1% vs 32.3%, p<0.001 and 16.7% vs 12.0%, p = 0.011). In restrictive lung function the prevalence of chronic rhinitis, cardiovascular disease, hyperlipemia and diabetes was higher compared to in Nlf (41.0% vs 32.3%, p = 0.017, 59.0% vs 41.0%, p<0.001, 29.2% vs.12.9%, p = 0.033, 20.9% vs 8.6%, p <0.001). In COPD and heart disease, 62.5% had chronic rhinitis and/or GERD, while in Nlf the corresponding proportion was 42.5%.

CONCLUSION

Co-morbid conditions such as cardiovascular disease, chronic rhinitis and gastroesophageal reflux were common in COPD. The overlap between heart disease, chronic rhinitis and GERD was large in COPD. Restrictive lung function did also identify a population with increased disease burden.

摘要

背景

局部和全身炎症与心血管等不同合并症之间的关系已在 COPD 的疾病过程和预后方面进行了讨论。

目的

评估心血管疾病、糖尿病、慢性鼻炎和胃食管反流等疾病在 COPD 中的发病率是否更高。

方法

从 2002-04 年 OLIN(瑞典北部阻塞性肺病)研究队列的临床随访中确定了所有根据 GOLD 标准诊断为 COPD 的患者(FEV1/FVC<0.70,n=993),并与 993 名性别和年龄匹配的无 COPD 参考患者(非 COPD,进一步分为正常和限制性肺功能)。使用合并症和症状的访谈数据。

结果

心血管合并症,包括心脏病、高血压、中风和间歇性跛行,在 COPD 中最为常见,且高于正常肺功能(Nlf)(50.1% vs 41.0%,p<0.001)。与 Nlf 相比,COPD 中慢性鼻炎和胃食管反流(GERD)的患病率更高(43.1% vs 32.3%,p<0.001 和 16.7% vs 12.0%,p=0.011)。在限制性肺功能中,与 Nlf 相比,慢性鼻炎、心血管疾病、高脂血症和糖尿病的患病率更高(41.0% vs 32.3%,p=0.017,59.0% vs 41.0%,p<0.001,29.2% vs.12.9%,p=0.033,20.9% vs 8.6%,p<0.001)。在 COPD 和心脏病患者中,62.5%有慢性鼻炎和/或 GERD,而在 Nlf 中,相应的比例为 42.5%。

结论

心血管疾病、慢性鼻炎和胃食管反流等合并症在 COPD 中很常见。在 COPD 中,心脏病、慢性鼻炎和 GERD 之间存在较大的重叠。限制性肺功能也确定了一个疾病负担增加的人群。

相似文献

1
Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function.轻度至中度 COPD 中的合并症:与正常和限制性肺功能的比较。
COPD. 2011 Dec;8(6):421-8. doi: 10.3109/15412555.2011.629858.
2
Association of heart diseases with COPD and restrictive lung function--results from a population survey.心脏疾病与 COPD 和限制性肺功能的关联——一项人群调查的结果。
Respir Med. 2013 Jan;107(1):98-106. doi: 10.1016/j.rmed.2012.09.011. Epub 2012 Nov 3.
3
Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.有呼吸道症状队列中,第一秒用力呼气容积(FEV1)下降与慢性阻塞性肺疾病发病的关系
COPD. 2007 Mar;4(1):5-13. doi: 10.1080/15412550601168358.
4
The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.瑞典北部阻塞性肺病慢性阻塞性肺疾病研究:设计、第一年参与情况及死亡率
Clin Respir J. 2008 Oct;2 Suppl 1:64-71. doi: 10.1111/j.1752-699X.2008.00086.x.
5
Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.根据疾病严重程度对慢性阻塞性肺疾病(COPD)的患病率、诊断不足情况以及吸烟的归因比例:来自瑞典北部阻塞性肺病研究的报告
Respir Med. 2006 Feb;100(2):264-72. doi: 10.1016/j.rmed.2005.04.029. Epub 2005 Jun 21.
6
Esophageal motility pattern and gastro-esophageal reflux in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的食管动力模式与胃食管反流
Hepatogastroenterology. 2012 Nov-Dec;59(120):2498-502. doi: 10.5754/hge10433.
7
The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.瑞典乌普萨拉慢性阻塞性肺疾病的患病率——慢性阻塞性肺病负担(BOLD)研究:基于人群的横断面研究
Clin Respir J. 2012 Apr;6(2):120-7. doi: 10.1111/j.1752-699X.2011.00257.x. Epub 2011 Jul 6.
8
Nocturnal gastroesophageal reflux, lung function and symptoms of obstructive sleep apnea: Results from an epidemiological survey.夜间胃食管反流、肺功能与阻塞性睡眠呼吸暂停症状:一项流行病学调查的结果。
Respir Med. 2012 Mar;106(3):459-66. doi: 10.1016/j.rmed.2011.12.004. Epub 2011 Dec 23.
9
Peripheral arterial disease in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的外周动脉疾病
Int Angiol. 2012 Oct;31(5):444-53.
10
A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.一项基于医院的关于慢性阻塞性肺疾病及其他疾病患者肺功能测试和运动耐量的研究。
J Indian Med Assoc. 2007 Oct;105(10):565-6, 568, 570 passim.

引用本文的文献

1
Restricted spirometry and cardiometabolic comorbidities: results from the international population based BOLD study.限制型肺功能与心脏代谢合并症:国际人群基础 BOLD 研究结果。
Respir Res. 2022 Feb 17;23(1):34. doi: 10.1186/s12931-022-01939-5.
2
Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients.慢性阻塞性肺疾病患者心血管合并症的管理
J Thorac Dis. 2020 May;12(5):2791-2802. doi: 10.21037/jtd.2020.03.60.
3
Diabetic lung disease: fact or fiction?糖尿病肺部疾病:事实还是虚构?
Rev Endocr Metab Disord. 2019 Sep;20(3):303-319. doi: 10.1007/s11154-019-09516-w.
4
Airflow Obstruction and Cardio-metabolic Comorbidities.气流阻塞与心血管代谢合并症。
COPD. 2019 Apr;16(2):109-117. doi: 10.1080/15412555.2019.1614550. Epub 2019 May 27.
5
Revealing Methodological Challenges in Chronic Obstructive Pulmonary Disease Studies Assessing Comorbidities: A Narrative Review.揭示慢性阻塞性肺疾病合并症研究中的方法学挑战:一项叙述性综述
Chronic Obstr Pulm Dis. 2019 Apr 9;6(2):166-177. doi: 10.15326/jcopdf.6.2.2018.0145.
6
Excess risk of major vascular diseases associated with airflow obstruction: a 9-year prospective study of 0.5 million Chinese adults.气流受限与主要血管疾病的额外风险:对50万中国成年人的9年前瞻性研究。
Int J Chron Obstruct Pulmon Dis. 2018 Mar 8;13:855-865. doi: 10.2147/COPD.S153641. eCollection 2018.
7
From COPD epidemiology to studies of pathophysiological disease mechanisms: challenges with regard to study design and recruitment process: Respiratory and Cardiovascular Effects in COPD (KOLIN).从慢性阻塞性肺疾病流行病学到病理生理疾病机制研究:研究设计与招募过程面临的挑战:慢性阻塞性肺疾病的呼吸和心血管效应(科林)
Eur Clin Respir J. 2017 Dec 17;4(1):1415095. doi: 10.1080/20018525.2017.1415095. eCollection 2017.
8
Defining COPD-Related Comorbidities, 2004-2014.2004 - 2014年慢性阻塞性肺疾病相关合并症的定义
Chronic Obstr Pulm Dis. 2014 May 6;1(1):51-63. doi: 10.15326/jcopdf.1.1.2014.0119.
9
Pre- and post-bronchodilator airway obstruction are associated with similar clinical characteristics but different prognosis - report from a population-based study.支气管扩张剂使用前后的气道阻塞具有相似的临床特征,但预后不同——一项基于人群的研究报告
Int J Chron Obstruct Pulmon Dis. 2017 Apr 24;12:1269-1277. doi: 10.2147/COPD.S127923. eCollection 2017.
10
Chronic Obstructive Pulmonary Disease and the Risk of Stroke.慢性阻塞性肺疾病与中风风险。
Ann Am Thorac Soc. 2017 May;14(5):754-765. doi: 10.1513/AnnalsATS.201611-932SR.